...
首页> 外文期刊>Journal of Hazardous Materials >Multi-route transmission potential of SARS-CoV-2 in healthcare facilities
【24h】

Multi-route transmission potential of SARS-CoV-2 in healthcare facilities

机译:SARS-COV-2在医疗保健设施中的多路线传输潜力

获取原文
获取原文并翻译 | 示例
           

摘要

Understanding the transmission mechanism of SARS-CoV-2 is a prerequisite to effective control measures. To investigate the potential modes of SARS-CoV-2 transmission, 21 COVID-19 patients from 12-47 days after symptom onset were recruited. We monitored the release of SARS-CoV-2 from the patients' exhaled breath and systematically investigated environmental contamination of air, public surfaces, personal necessities, and the drainage system. SARS-CoV-2 RNA was detected in 0 of 9 exhaled breath samples, 2 of 8 exhaled breath condensate samples, 1 of 12 bedside air samples, 4 of 132 samples from private surfaces, 0 of 70 samples from frequently touched public surfaces in isolation rooms, and 7 of 23 feces-related air/surface/water samples. The maximum viral RNA concentrations were 1857 copies/m3 in the air, 38 copies/cm2 in sampled surfaces and 3092 copies/mL in sewage/wastewater samples. Our results suggest that nosocomial transmission of SARS-CoV-2 can occur via multiple routes. However, the low detection frequency and limited quantity of viral RNA from the breath and environmental specimens may be related to the reduced viral load of the COVID-19 patients on later days after symptom onset. These findings suggest that the transmission dynamics of SARS-CoV-2 differ from those of SARS-CoV in healthcare settings.
机译:了解SARS-COV-2的传输机制是有效控制措施的先决条件。为了探讨SARS-COV-2变速器的潜在模式,招募了21例症状发作后12-47天的Covid-19患者。我们监测了SARS-COV-2的释放,从患者的呼出呼吸和系统地调查了空气,公共场所,个人必需品和排水系统的环境污染。在9个呼出的呼吸样品中检测到SARS-COV-2 RNA,8个呼出的呼吸冷凝物样品中的2个,12个床侧空气样品中的1个,其中4个来自私人表面的样品中的4个,70个样品中的70个样本,来自经常触及的公共表面的分离。房间和23个粪便相关的空气/水样中的7间。在空气中,最大病毒RNA浓度为1857份/ m3,在污水/废水样品中在采样表面中的38份/ cm 2和3092拷贝/ ml。我们的研究结果表明,SARS-COV-2的医院传输可以通过多条路线进行。然而,来自呼吸和环境样本的低检测频率和有限的病毒RNA可能与Covid-19患者的病毒载量降低有关,在症状发作后的晚些时候。这些发现表明,SARS-COV-2的传输动态与医疗保健设置中的SARS-COV的传输动态不同。

著录项

  • 来源
    《Journal of Hazardous Materials》 |2021年第2期|123771.1-123771.6|共6页
  • 作者单位

    Zhejiang Univ Dept Lab Med Affiliated Hosp 1 Coll Med Hangzhou 310000 Peoples R China|Key Lab Clin Vitro Diagnost Tech Zhejiang Prov Hangzhou 310000 Peoples R China|Zhejiang Univ Inst Lab Med Hangzhou 310000 Peoples R China;

    Zhejiang Univ State Key Lab Diag & Treatment Infect Dis Natl Clin Res Ctr Infect Dis Affiliated Hosp 1 Co Collaborat Innovat Ctr Diag & Treatment Infect Di Hangzhou 310000 Peoples R China;

    Zhejiang Univ State Key Lab Diag & Treatment Infect Dis Natl Clin Res Ctr Infect Dis Affiliated Hosp 1 Co Collaborat Innovat Ctr Diag & Treatment Infect Di Hangzhou 310000 Peoples R China;

    Zhejiang Univ Dept Lab Med Affiliated Hosp 1 Coll Med Hangzhou 310000 Peoples R China|Key Lab Clin Vitro Diagnost Tech Zhejiang Prov Hangzhou 310000 Peoples R China|Zhejiang Univ Inst Lab Med Hangzhou 310000 Peoples R China;

    Zhejiang Univ Dept Lab Med Affiliated Hosp 1 Coll Med Hangzhou 310000 Peoples R China|Key Lab Clin Vitro Diagnost Tech Zhejiang Prov Hangzhou 310000 Peoples R China|Zhejiang Univ Inst Lab Med Hangzhou 310000 Peoples R China;

    Zhejiang Univ State Key Lab Diag & Treatment Infect Dis Natl Clin Res Ctr Infect Dis Affiliated Hosp 1 Co Collaborat Innovat Ctr Diag & Treatment Infect Di Hangzhou 310000 Peoples R China;

    Zhejiang Univ State Key Lab Diag & Treatment Infect Dis Natl Clin Res Ctr Infect Dis Affiliated Hosp 1 Co Collaborat Innovat Ctr Diag & Treatment Infect Di Hangzhou 310000 Peoples R China;

    Zhejiang Univ State Key Lab Diag & Treatment Infect Dis Natl Clin Res Ctr Infect Dis Affiliated Hosp 1 Co Collaborat Innovat Ctr Diag & Treatment Infect Di Hangzhou 310000 Peoples R China;

    Zhejiang Univ Dept Lab Med Affiliated Hosp 1 Coll Med Hangzhou 310000 Peoples R China|Key Lab Clin Vitro Diagnost Tech Zhejiang Prov Hangzhou 310000 Peoples R China|Zhejiang Univ Inst Lab Med Hangzhou 310000 Peoples R China;

    Zhejiang Univ Inst Refrigerat & Cryogen Key Lab Refrigerat & Cryogen Technol Zhejiang Pro Hangzhou 310000 Peoples R China;

    Univ Hong Kong Dept Mech Engn Pokfulam Hong Kong 999077 Peoples R China;

    Zhejiang Univ State Key Lab Diag & Treatment Infect Dis Natl Clin Res Ctr Infect Dis Affiliated Hosp 1 Co Collaborat Innovat Ctr Diag & Treatment Infect Di Hangzhou 310000 Peoples R China;

    Univ Hong Kong Sch Publ Hlth Li Ka Shing Fac Med Hong Kong 999077 Peoples R China;

    Zhejiang Univ Dept Nosocomial Infect Control Coll Med Hangzhou 310000 Peoples R China;

    Zhejiang Univ Inst Refrigerat & Cryogen Key Lab Refrigerat & Cryogen Technol Zhejiang Pro Hangzhou 310000 Peoples R China;

    Zhejiang Univ Dept Lab Med Affiliated Hosp 1 Coll Med Hangzhou 310000 Peoples R China|Key Lab Clin Vitro Diagnost Tech Zhejiang Prov Hangzhou 310000 Peoples R China|Zhejiang Univ Inst Lab Med Hangzhou 310000 Peoples R China|Zhejiang Univ State Key Lab Diag & Treatment Infect Dis Natl Clin Res Ctr Infect Dis Affiliated Hosp 1 Co Collaborat Innovat Ctr Diag & Treatment Infect Di Hangzhou 310000 Peoples R China;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    COVID-19; SARS-CoV-2; Exhaled breath; Aerosol; Environmental sampling;

    机译:Covid-19;SARS-COV-2;呼气呼吸;气溶胶;环境抽样;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号